Lexeo Therapeutics Inc (LXEO)

Stock-Based Compensation

$13.81M

TTM · Period ending: · USD

LXEO logo

LXEO Stock-Based Compensation

Latest reported$13.81M
LXEO TTM Stock-Based Comp ($952.00K → $13.81M)
High-resolution chart · PNG

LXEO stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lexeo Therapeutics Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
13,809,000
11,190,000
12,132,000
12,926,000
14,065,000
13,840,000
12,474,000
9,771,000
6,854,000
4,008,000
2,074,000
1,791,000
1,349,000
1,349,000
952,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.